Authors
Zhuo Jia, Yibo Chen, Zhenze Yang, Kan Liu, Jialong Song, Qilong Jiao, Cheng Peng, Chenzhi Zhao, Xinlin Peng, Shangwei Li, Xiaohui Ding, Qiuyang Li, Haiyi Wang, Maowei Gong, Yajun Xu, Junnan Xu, Sascha Pahernik, Xu Zhang, Xin Ma, Qingbo Huang
Published in
World journal of urology. Volume 44. Issue 1. Nov 17, 2026. Epub Nov 17, 2026.
Abstract
To achieve the dual goals of effective tumor control and maximal renal function preservation, we have proposed a standardized robot-assisted nephron-sparing surgery combined with venous thrombectomy for classic renal angiomyolipoma (AML) with venous tumor thrombus (VTT). This study aimed to evaluate the technical feasibility and clinical rationality of this innovative surgical technique.
We retrospectively analyzed 17 patients who underwent robot-assisted partial nephrectomy (RAPN) with venous tumor thrombectomy and 16 patients who underwent robot-assisted radical nephrectomy with venous tumor thrombectomy. The radical-nephrectomy cohort served as a historical clinical comparator. The modified thrombectomy strategy followed the proposed "NSS" technical principles. Functional and oncological outcomes were analyzed.
All procedures were completed without open conversion or intraoperative tumor-thrombus dislodgement, and no RAPN case required conversion to radical nephrectomy. The RAPN group had shorter operative time (160.0 vs. 232.5 min, p=0.021), shorter left renal vein clamping (3.0 vs. 16.5 min, p<0.001) and IVC clamping time (3.0 vs. 16.0 min, p<0.001), and better renal function preservation (p<0.001). Renal function was better preserved in RAPN group, primarily reflecting retention of the affected kidney. During the available follow-up (median 9 months in the RAPN group and 55 months in the Control group), no recurrence was detected; however, follow-up was insufficient for comparative or long-term oncological conclusions.
RAPN with venous tumor thrombectomy appears technically feasible in patients with classic renal AML with VTT. This surgical approach could better preserve renal function, but the long-term outcomes require confirmation in larger series with longer follow-up.
PMID:
43043499
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0